Approvals/CIMA-AEMPS/GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d09f75afdeadb5ef
Drug Cima Aemps Name: GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 88793
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-04-17
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 30 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 17, 2023

Approval ID

d09f75afdeadb5ef

Type

Standard